GlassScriptPhysician profile
Ricardo A Ramos
NPI 1568574770
$5,353.35
in general payments reported to CMS, 2019-2025
24 companies · $1,755 in 2025
The $1,755 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $292 · 2021: $129 · 2022: $883 · 2023: $410 · 2024: $1,154 · 2025: $1,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,305 · Travel and Lodging: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.19 |
| Travel and Lodging | $1,013.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,150.64 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Abbott Laboratories | $1,002.15 | 2019-2025 | Aveir, Ensite, Cardiomems |
| Biotronik INC. | $713.69 | 2019-2025 | Solia, Selectra, Amvia Edge |
| Boston Scientific Corporation | $492.91 | 2020-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $415.36 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Linq II |
| Pfizer INC. | $276.64 | 2019-2025 | |
| Amgen INC. | $224.67 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $205.61 | 2019-2023 | |
| Heartflow, INC. | $201.67 | 2022 | |
| Janssen Pharmaceuticals, INC | $138.82 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $112.01 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $102.23 | 2019-2025 | |
| Altathera Pharmaceuticals LLC | $42.39 | 2023 | Sotalol Hydrochloride |
| Daiichi Sankyo INC. | $41.49 | 2024-2025 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.63 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.94 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $29.88 | 2019-2020 | |
| Abbvie INC. | $26.94 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $25.07 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $18.83 | 2024 | Amvuttra |
| Chiesi USA, INC. | $16.38 | 2022 | |
| Impulse Dynamics (USA) INC. | $15.48 | 2023 | Optimizer |
| Braemar Manufacturing, LLC | $13.97 | 2019 | |
| Philips North America LLC | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.